MX3007E - Procedimiento mejorado para hacer un dispensador monolitico de agente activo - Google Patents

Procedimiento mejorado para hacer un dispensador monolitico de agente activo

Info

Publication number
MX3007E
MX3007E MX001433U MX143375U MX3007E MX 3007 E MX3007 E MX 3007E MX 001433 U MX001433 U MX 001433U MX 143375 U MX143375 U MX 143375U MX 3007 E MX3007 E MX 3007E
Authority
MX
Mexico
Prior art keywords
active agent
making
dispersion
agent dispenser
polymeric matrix
Prior art date
Application number
MX001433U
Other languages
English (en)
Spanish (es)
Inventor
Alan S Michaels
Felix Theeuwes
Richard W Baker
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX3007E publication Critical patent/MX3007E/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX001433U 1974-06-07 1975-06-06 Procedimiento mejorado para hacer un dispensador monolitico de agente activo MX3007E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US477297A US3923939A (en) 1974-06-07 1974-06-07 Process for improving release kinetics of a monolithic drug delivery device

Publications (1)

Publication Number Publication Date
MX3007E true MX3007E (es) 1980-01-28

Family

ID=23895337

Family Applications (1)

Application Number Title Priority Date Filing Date
MX001433U MX3007E (es) 1974-06-07 1975-06-06 Procedimiento mejorado para hacer un dispensador monolitico de agente activo

Country Status (10)

Country Link
US (1) US3923939A (enrdf_load_stackoverflow)
JP (1) JPS6043327B2 (enrdf_load_stackoverflow)
CA (1) CA1047403A (enrdf_load_stackoverflow)
CH (1) CH611160A5 (enrdf_load_stackoverflow)
DE (1) DE2525061C2 (enrdf_load_stackoverflow)
FR (1) FR2273515A1 (enrdf_load_stackoverflow)
GB (1) GB1477545A (enrdf_load_stackoverflow)
IT (1) IT1036192B (enrdf_load_stackoverflow)
MX (1) MX3007E (enrdf_load_stackoverflow)
SE (1) SE405803B (enrdf_load_stackoverflow)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
US4145408A (en) * 1976-08-16 1979-03-20 The Procter & Gamble Company Controlled release article
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
US4190642A (en) * 1978-04-17 1980-02-26 Alza Corporation Ocular therapeutic system for dispensing a medication formulation
US4156604A (en) * 1978-09-15 1979-05-29 Minnesota Mining And Manufacturing Company Controlled delivery of corrosion inhibitors for silver recovery cartridges
US4333850A (en) * 1979-06-15 1982-06-08 Borg-Warner Corporation Filled polymer composition for automatic addition of a corrosion inhibitor to a coolant system
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
JPS5931701A (ja) * 1982-08-16 1984-02-20 Nitto Electric Ind Co Ltd 液状活性物質含有膜及びその製造方法
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4564364A (en) * 1983-05-26 1986-01-14 Alza Corporation Active agent dispenser
GB8331546D0 (en) * 1983-11-25 1984-01-04 Exxon Research Engineering Co Polymeric compositions
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4629619A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4629620A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
DE3585530D1 (de) * 1984-12-03 1992-04-09 Baxter Int Verabreichungsanordnung fuer arzneimittel zum vorbeugen lokaler und systemischer toxizitaet.
US4874366A (en) * 1984-12-03 1989-10-17 Baxter Internatiional Inc. Housing enabling passive mixing of a beneficial agent with a diluent
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
ATE71287T1 (de) * 1986-06-13 1992-01-15 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung
US4917895A (en) * 1987-11-02 1990-04-17 Alza Corporation Transdermal drug delivery device
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US5229148A (en) * 1989-04-19 1993-07-20 Wm. Wrigley Jr. Company Method of combining active ingredients with polyvinyl acetates
US5165944A (en) * 1989-04-19 1992-11-24 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5108762A (en) * 1989-04-19 1992-04-28 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5154939A (en) * 1989-04-19 1992-10-13 Wm. Wrigley Jr. Company Use of salt to improve extrusion encapsulation of chewing gum ingredients
US4978537A (en) * 1989-04-19 1990-12-18 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5198251A (en) * 1989-04-19 1993-03-30 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI904598A7 (fi) * 1989-10-10 1991-04-11 Wrigley W M Jun Co Kuidunkehruutekniikalla valmistetut ainetta vähitellen vapauttavat rakenteet
JPH03287525A (ja) * 1990-04-03 1991-12-18 Toichi Chikuma 貼付鎮痛具
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
JPH0421521U (enrdf_load_stackoverflow) * 1990-06-14 1992-02-24
US5128155A (en) * 1990-12-20 1992-07-07 Wm. Wrigley Jr. Company Flavor releasing structures for chewing gum
US5271736A (en) * 1991-05-13 1993-12-21 Applied Medical Research Collagen disruptive morphology for implants
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5962011A (en) * 1993-12-06 1999-10-05 Schering-Plough Healthcare Products, Inc. Device for delivery of dermatological ingredients
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5819742A (en) * 1996-11-06 1998-10-13 Family Health International Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both
AU739469B2 (en) 1996-12-20 2001-10-11 Alza Corporation Gel composition and methods
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
IL135061A0 (en) * 2000-03-14 2001-05-20 Ahron Jodaikin Strategic targeted fluoridation and chemical treatment of teeth
US20050175959A1 (en) * 2000-03-14 2005-08-11 Coll Partners Ltd. System for the controlled delivery of an active material to a dental site
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
WO2002026139A1 (en) * 2000-09-29 2002-04-04 Cordis Corporation Coated medical devices
EP1446099B1 (en) * 2001-11-14 2009-07-15 Durect Corporation Injectable depot composition
EP1446101B1 (en) 2001-11-14 2011-03-23 Durect Corporation Catheter injectable depot compositions and uses thereof
EP1509182A4 (en) * 2002-05-31 2009-12-30 Titan Pharmaceuticals Inc IMPLANTABLE POLYMERS DEVICE FOR THE DELAYED RELEASE OF BUPRENORPHINE
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
DE60325742D1 (de) 2002-07-31 2009-02-26 Alza Corp Injizierbare multimodale polymere depotzusammensetzungen und ihre verwendungen
NZ537955A (en) 2002-07-31 2007-10-26 Alza Corp Injectable depot compositions and uses thereof
ES2359977T3 (es) * 2003-03-31 2011-05-30 Titan Pharmaceuticals, Inc. Dispositivo polimérico implantable para liberación sostenida de agonista de dopamina.
US7850453B2 (en) * 2007-08-08 2010-12-14 Coll Partners Ltd. Reshapable device for fixation at a dental site
USRE48948E1 (en) * 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
BRPI1008030A2 (pt) * 2009-02-23 2016-03-15 Qlt Plug Delivery Inc implantes lacrimais e métodos relacionados
ES2603057T3 (es) * 2009-10-30 2017-02-23 Aton Pharma, Inc. Dispositivos de administración ocular de fármacos
US9138308B2 (en) 2010-02-03 2015-09-22 Apollo Endosurgery, Inc. Mucosal tissue adhesion via textured surface
US9205577B2 (en) * 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
PL2569021T3 (pl) * 2010-05-11 2017-07-31 Allergan, Inc. Kompozycje, sposoby wytwarzania i zastosowania czynnika porotwórczego
US9668844B2 (en) 2013-11-06 2017-06-06 Colldent Y.A Ltd Device for fixation at a dental site
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
KR20230145053A (ko) 2021-01-12 2023-10-17 듀렉트 코퍼레이션 지속 방출 약물 전달 시스템 및 관련 방법
EP4215181A1 (en) * 2022-01-21 2023-07-26 Sever Pharma Solutions An intravaginal ring

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3639583A (en) * 1968-06-28 1972-02-01 Goodrich Co B F Biocidal elastomeric compositions
US3700380A (en) * 1970-10-01 1972-10-24 Tecna Corp Surface or lining compatible with blood or other tissue
GB1412983A (en) * 1971-11-30 1975-11-05 Debell & Richardson Method of producing porous plastic materials
FR2183546B1 (enrdf_load_stackoverflow) * 1972-05-10 1975-06-20 Servier Lab
JPS49118827A (enrdf_load_stackoverflow) * 1973-03-27 1974-11-13
JPS506709A (enrdf_load_stackoverflow) * 1973-05-18 1975-01-23

Also Published As

Publication number Publication date
US3923939A (en) 1975-12-02
FR2273515A1 (fr) 1976-01-02
JPS5112920A (enrdf_load_stackoverflow) 1976-01-31
DE2525061A1 (de) 1976-01-02
DE2525061C2 (de) 1985-08-22
FR2273515B1 (enrdf_load_stackoverflow) 1980-02-15
CH611160A5 (enrdf_load_stackoverflow) 1979-05-31
JPS6043327B2 (ja) 1985-09-27
SE405803B (sv) 1979-01-08
GB1477545A (en) 1977-06-22
CA1047403A (en) 1979-01-30
IT1036192B (it) 1979-10-30
SE7506099L (sv) 1975-12-08

Similar Documents

Publication Publication Date Title
MX3007E (es) Procedimiento mejorado para hacer un dispensador monolitico de agente activo
ES360946A1 (es) Mejoras en la fabricacion de dispositivos anulares elasti- cos medicados para uso intravaginal en mamiferos hembras.
DK104194C (da) Fremgangsmåde til fremstilling af lægemidler i form af tabletter eller lignende smålegemer.
ES248340A1 (es) Método para obtener una composicion en forma de dosificacion oral
GB987556A (en) Process for reducing the dimensions of monocrystalline bodies of semiconductor material by polishing
BE612393A (fr) Dispositif pour obtenir un corps semiconducteur pur, de préférence du silicium.
BR7403339D0 (pt) Dispositivo para liberacao de agente ativo e processo para pooducao do mesmo
GB816466A (en) Improvements in semi-conductor devices utilizing germanium
FR1182331A (fr) Dispositifs semi-conducteurs et leur procédé de fabrication
JPS5328384A (en) Production method of semiconductor device
GB990401A (en) Crystallization process
ES348194A1 (es) Procedimiento para estabilizar cuerpos con forma a base de poliolefinas.
GB987971A (en) Process for reducing the dimensions of monocrystalline bodies of semiconductor material
CH296976A (de) Konische Becherkapsel aus Folienmaterial und Verfahren zu deren Herstellung.
USD137496S (en) Design fob a device for holding capsules, pills, and the like
FR1270317A (fr) Procédé de traitement de matières solides, en particulier des matières semi-conductrices
BE605180A (fr) Dispositifs semi-conducteurs et procédés pour leur fabrication.
FR1277532A (fr) Procédé de fabrication de matières polymères contenant du silicium, telles que les silarylènes
FR1225235A (fr) Procédé de fabrication de pièces denses en carbure de silicium
KAWAMURA Present state of the farm pond fish culture in Osaka Pref.
ES283408A1 (es) Un procedimiento de fabricación de acolchados de material de elástico esponjoso de tipo compuesto
BE594462A (fr) Perfectionnements aux dispositifs semi-conducteurs du genre comprénant un corps semi-conducteur en phosphure de gallium, et procédé de fabrication de ces dispositifs.
FR1329316A (fr) Procédé de fabrication de coton hydrophile
FR1173204A (fr) Dispositif pour le traitement de mélanges en particulier pour la préparation de la viscose
ES145338A1 (es) Perfeccionamientos en el procedimiento de fabricación de pastillas comprimidas de varias formas.